About Steradian Technologies
Steradian Technologies is a company based in Houston (United States) founded in 2017. Steradian Technologies offers products and services including The RUMI. Steradian Technologies operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
- Headquarter Houston, United States
- SectorsHealthcare
- Website steradian-tech.com
- Social LinkedIn
- Legal Name Steradian Technologies, Inc.
- Investors
Products & Services of Steradian Technologies
Steradian Technologies offers a comprehensive portfolio of products and services, including The RUMI.
Portable tool for detecting infectious diseases from breath in 30 seconds.
Funding Insights of Steradian Technologies
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Steradian Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2022 | – | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Steradian Technologies
Steradian Technologies has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Gates Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Charitable foundation investments on poverty reduction and healthcare | 2000 | gatesfoundation.org | Seattle, United States |
Investor details for Steradian Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Steradian Technologies
1 people are tracked at Steradian Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Asma Mirza | CEO | Leadership |
Complete people profiles for Steradian Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Steradian Technologies
2 dated milestones of Steradian Technologies across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Steradian Technologies is founded.
- Funding First funding round.
Competitors of Steradian Technologies
Steradian Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prenetics.com | 2009 | Hong Kong, China | $67.65M | – | Health risks are identified through online genetic and diagnostic testing. | |
| opgen.com | 2002 | Rockville, United States | $77.51M | 100 | Developer of diagnostics and bioinformatics platforms for providers | |
| dayzerodiagnostics.com | 2016 | Boston, United States | $48.6M | 48 | Genome sequencing diagnostics for infectious diseases are developed. | |
| clearlabs.com | 2014 | Menlo Park, United States | $171.09M | 55 | Food safety technologies are provided for pathogen identification. | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| curetis.com | 2007 | Holzgerlingen, Germany | $127.14M | 55 | Molecular diagnostics platform is provided for infectious disease detection. | |
| seegene.com | 2000 | Seoul, South Korea | – | – | Developer of molecular diagnostic kits to detect infectious and genetic diseases | |
| noze.ca | 2015 | Montreal, Canada | $5M | – | Developer of AI-based platform for air-borne disease detection | |
| pathoquest.com | 2010 | Paris, France | $9.99M | – | Next-generation sequencing is provided for microbiology testing applications. |
Detailed competitors of Steradian Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Steradian Technologies
Complete news archive for Steradian Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Steradian Technologies
10 companies that operate in the same segment as Steradian Technologies (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Steradian Technologies
Steradian Technologies was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Steradian Technologies is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Asma Mirza is the current CEO of Steradian Technologies.
Steradian Technologies was founded in 2017 in Houston, United States, within the medical diagnostics sector. A portable, non-invasive device called RUMI is provided for detecting infectious diseases through photon-based analysis of breath samples. Respiratory conditions such as COVID-19, influenza, RSV, and tuberculosis are tested, along with non-communicable diseases including early-stage lung cancer and COPD. Operations focus on point-of-care diagnostics for global health applications.
Steradian Technologies's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.
Steradian Technologies offers The RUMI.
Steradian Technologies has 1 investor. Key investors include Gates Foundation.
Steradian Technologies operates through Steradian Technologies, Inc..